C9399 Navigating the world of medical billing can be complex, particularly when it comes to newer and highly sought-after medications like tirzepatide.2024年9月9日—In 2023, the FDA approved another GLP-1 drug for weight loss,tirzepatide, under the brand name Zepbound. Not all GLP-1 drugs are FDA ... For healthcare providers, accurately identifying the correct HCPCS code is crucial for reimbursement and proper documentation. This article delves into the specifics of tirzepatide HCPCS code assignment, exploring the nuances for both Mounjaro and Zepbound, and providing insights for medical professionals.
Tirzepatide is an innovative injectable medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is prescribed for two primary indications under different brand names: Mounjaro for improving glycemic control in adults with type 2 diabetes mellitus (T2DM) and Zepbound for weight loss in adults who meet specific criteria for obesity or overweight with weight-related conditions, alongside diet and exercise....code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN ... (tirzepatide) Injection, for subcutaneous use
Initial U.S. Approval ... The efficacy of tirzepatide in managing these conditions has led to increased demand and a need for clear billing protocols.Pharmacy Drug Policy & Procedure
While a universal, single HCPCS code specifically for tirzepatide may not always be readily apparent, several codes are referenced in clinical policies and billing guidance.2025年3月28日—the right to revise this policy as needed.HCPCS. CODE. DESCRIPTION. NA. AVAILABLE DOSAGE FORMS: Zepbound SOLN 2.5MG/0.5ML, 5MG/ ... It's important to note that HCPCS codes are established by the Centers for Medicare & Medicaid Services (CMS) and are used to report medical procedures and services, including drugs and biologicals, for billing purposes.
One of the most frequently encountered HCPCS codes associated with tirzepatide, particularly when specific codes are not yet assigned or are removed, is HCPCS J3490, which designates "Unclassified drugs." This code serves as a placeholder for drugs that do not have a more specific assigned code.Zepbound, Prior Authorization Resource Guide Indeed, multiple sources indicate that Mounjaro (tirzepatide) has been associated with HCPCS codes C9399 and J3490. Similarly, Zepbound has also been linked to HCPCS J3490 and J3590 (Unclassified biologics) in certain contexts, such as for obstructive sleep apnea. The use of J3490 for tirzepatide is confirmed in various self-administered drug exclusion lists, highlighting its role in the billing landscape.
Furthermore, the article "Article - Self-Administered Drug Exclusion List: (A53066)" explicitly mentions Mounjaro and Zepbound (tirzepatide) in relation to excluded codes. It notes that HCPCS code C9040 was deleted, implying a shift towards other coding mechanisms. The inclusion of tirzepatide on self-administered medication lists, often referencing J3490, underscores the contemporary billing practices for this medication when it’s administered by the patient.
It's also worth mentioning that some documents refer to a different coding system, such as the SCTID:41145911000001106 for tirzepatideThe drugs represented byHCPCS codes J0801 and J0802are administered by IM or SQ, therefore they require the JB modifier to be reported for SQ administration .... While not a HCPCS code, such identifiers are important for unique drug identification within certain healthcare systems. For the uninitiated, seeking information on HCPCS Codes in general is recommended for a comprehensive understanding.
The search for tirzepatide HCPCS code often leads to related queries such as Zepbound HCPCS code, Mounjaro jcode, and the specific code J3490. Understanding these connections is vital for accurate coding.Zepbound (tirzepatide) NC C29112-A For instance, the search for Zepbound for weight loss indicates a common use case that necessitates correct billing.
When considering CPT Codes for similar medications, such as CPT code for semaglutide injection or CPT code for Wegovy injection, it highlights the broader context of injectable weight loss and diabetes medications and the importance of distinguishing between different drug classes and their respective HCPCS and CPT CodesATCcode· A10BX16 (WHO). Legal status. Legal status. AU : S4 (Prescription only) ... A 2021 meta-analysis found that over one year of clinical use,tirzepatide....
Healthcare providers should be aware of the specific dosage forms and strengths provided by manufacturers. For example, Zepbound is available in various dosages, including SOLN 2.HNCA.CP.CPA.359 Tirzepatide (Zepbound)5MG/0.5ML and 5MG. Each formulation and its administration must be correctly documented. The NDC code 54568-342-20 is a specific identifier for tirzepatide injection, solution, aiding in precise product identification. Similarly, NDC Code(s): 0002-0152-01, 0002-0152-04, 0002-0152-61, 0002-0243-01 refers to other product identifiers for tirzepatide injection, solutionMounjaro® (tirzepatide) Zepbound™ (tirzepatide), 11/19/2022, N/A, Apparent ... Under Excluded CPT/HCPCS Codes – Table FormatHCPCS code C9040was deleted ....
The coding for medications like tirzepatide can evolve as they become more widely used and payers update their policies. For example, the mention of deleted codes like HCPCS code C9040 signifies this dynamic nature. Healthcare providers must stay abreast of the latest updates from CMS and other relevant regulatory bodies. Staying informed about HCPCS is a continuous process.
For specific policy clarifications, healthcare professionals may refer to clinical policy documents, such as those referencing tirzepatide (Zepbound) with codes like NH.PMN.298 or those from entities like Health Alliance Medical Plans. These documents often provide detailed criteria for approval and the necessary coding information.RxCUI 2601723 - tirzepatide - RxNav - NIH The involvement of organizations like the NIH RxNav also provides valuable resources for drug information, including RxCUI 2601723 for tirzepatide.2025年2月10日—Tirzepatideis the active ingredient in the drugs Zepbound and Mounjaro. Zepbound is approved for weight loss and obstructive sleep apnea, while ...
It is essential for providers to actively seek out and adhere to the most current reimbursement guidelines.Type 2 Diabetes Mellitus. Mounjaro only. Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. This proactive approach ensures that claims are processed efficiently and accurately, minimizing disruptions in revenue cycle managementArticle - Self-Administered Drug Exclusion List: (A52571). The reference to A10BX16 as an ATC code for tirzepatide indicates its classification within the Anatomical Therapeutic Chemical (ATC) Classification System, providing an international perspective on its therapeutic role.
Ultimately, understanding the intricacies of tirzepatide HCPCS code assignment is vital for healthcare providersDIN 02532913 - 7.5 mg/0.5 mLtirzepatide, solution, subcutaneous injection; DIN 02532921 - 10 mg/0.5 mLtirzepatide, solution, subcutaneous injection; DIN .... By staying informed about available codes, particularly J3490, and remaining diligent in following evolving medical billing standards, professionals can ensure proper reimbursement and continue to offer these valuable treatments to their patients. The fact that tirzepatide is an injectable medication that's used along with diet and exercise emphasizes its role as a therapeutic agent that requires careful administrative and financial consideration.
Join the newsletter to receive news, updates, new products and freebies in your inbox.